Table II.
Parameter | HR (95% CI)* | P-value | HR (95% CI)** | P-value |
---|---|---|---|---|
Histopathology: | ||||
Epithelioid | Ref | 0.001 | Ref | 0.001 |
Others | 3.70 (1.69–8.08) | 4.51 (1.90–10.67) | ||
Stage: | ||||
I–II | Ref | 0.020 | Ref | 0.027 |
III–IV | 2.90 (1.18–7.10) | 2.92 (1.13–7.59) | ||
KPS: | ||||
≥ 80 | Ref | 0.040 | Ref | 0.001 |
< 80 | 3.05 (1.05–8.83) | 7.27 (2.22–23.79) | ||
MDK: | ||||
Low | Ref | 0.021 | Ref | 0.007 |
High | 2.91 (1.17–7.23) | 3.89 (1.46–10.40) | ||
SDC1: | ||||
High | Ref | 0.009 | Ref | 0.053 |
Low | 3.47 (1.37-8.77) | 2.77 (0.99-7.74) | ||
HAS2: | ||||
High | Ref | 0.005 | Ref | 0.008 |
Low | 2.72 (1.35–5.46) | 2.77 (1.30–5.92) | ||
SESN1: | ||||
High | Ref | 0.014 | Ref | 0.014 |
Low | 3.67 (1.30-10.37) | 4.0 (1.33-12.01) | ||
LAMA4: | ||||
High | Ref | 0.472 | ||
Low | 0.80 (0.44-1.46) | |||
FBLN3: | ||||
Low | Ref | 0.657 | ||
High | 0.78 (0.25–2.38) |
Stage- and KPS-adjusted hazard ratios.
Multivariate hazard ratios.